​

LeMaitre Vascular (LMAT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LMAT Stock Forecast

LeMaitre Vascular (LMAT) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $110.00, with a high of $110.00 and a low of $110.00. This represents a 35.18% increase from the last price of $81.37.

$55 $66 $77 $88 $99 $110 High: $110 Avg: $110 Low: $110 Last Closed Price: $81.37

LMAT Stock Rating

LeMaitre Vascular stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (68.75%), 5 Hold (31.25%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 5 11 Strong Sell Sell Hold Buy Strong Buy

LMAT Price Target Upside V Benchmarks

TypeNameUpside
StockLeMaitre Vascular35.18%
SectorHealthcare Stocks 23.68%
IndustryMedical Instruments & Supplies Stocks25.40%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$102.00
Last Closing Price$81.37$81.37$81.37
Upside/Downside--25.35%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25236--11
May, 25236--11
Apr, 25236--11
Mar, 25236--11
Feb, 25343--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 28, 2025Lake Street$110.00$91.8519.76%35.18%
Oct 15, 2024Ross OsbornCantor Fitzgerald$96.00$92.144.19%17.98%
Aug 20, 2024Daniel StauderJMP Securities$100.00$85.5316.92%22.90%
Apr 26, 2024Rick WiseStifel Nicolaus$75.00$65.4614.57%-7.83%
Sep 06, 2023Suraj KaliaOppenheimer$70.00$56.7123.44%-13.97%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 28, 2025Lake StreetBuyBuyhold
Nov 01, 2024OppenheimerOutperformOutperformhold
Oct 15, 2024JMP SecuritiesNeutralNeutralhold
Oct 15, 2024Cantor FitzgeraldNeutralinitialise
Aug 20, 2024JMP SecuritiesOutperformOutperformhold
May 03, 2024JMP SecuritiesOutperformOutperformhold
Sep 06, 2023OppenheimerOutperforminitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.05$1.27$0.94$1.36$1.96---
Avg Forecast$0.99$1.28$0.93$1.32$1.94$2.16$2.38$2.60
High Forecast$1.01$1.31$0.95$1.33$1.96$2.27$2.55$2.65
Low Forecast$0.97$1.26$0.90$1.30$1.86$2.05$2.30$2.54
Surprise %6.06%-0.78%1.08%3.03%1.03%---

Revenue Forecast

$100M $140M $180M $220M $260M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$129.37M$154.42M$161.65M$193.48M$219.86M---
Avg Forecast$127.40M$154.61M$161.70M$193.61M$220.03M$240.15M$258.75M$284.96M
High Forecast$129.64M$157.33M$164.10M$194.27M$220.62M$243.71M$259.01M$290.59M
Low Forecast$125.44M$152.24M$158.05M$193.45M$219.77M$235.60M$258.49M$276.26M
Surprise %1.55%-0.12%-0.03%-0.06%-0.07%---

Net Income Forecast

$20M $32M $44M $56M $68M $80M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$21.22M$26.91M$20.64M$30.11M$44.04M---
Avg Forecast$63.46M$26.23M$26.90M$30.11M$42.86M$49.79M$56.17M$58.19M
High Forecast$76.16M$31.47M$32.28M$36.13M$43.95M$50.82M$57.18M$59.42M
Low Forecast$50.77M$20.98M$21.52M$24.08M$41.77M$45.91M$51.57M$56.95M
Surprise %-66.56%2.59%-23.28%-2.74%---

LMAT Forecast FAQ

Is LeMaitre Vascular stock a buy?

LeMaitre Vascular stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LeMaitre Vascular is a favorable investment for most analysts.

What is LeMaitre Vascular's price target?

LeMaitre Vascular's price target, set by 16 Wall Street analysts, averages $110 over the next 12 months. The price target range spans from $110 at the low end to $110 at the high end, suggesting a potential 35.18% change from the previous closing price of $81.37.

How does LeMaitre Vascular stock forecast compare to its benchmarks?

LeMaitre Vascular's stock forecast shows a 35.18% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the medical instruments & supplies stocks industry (25.40%).

What is the breakdown of analyst ratings for LeMaitre Vascular over the past three months?

  • June 2025: 18.18% Strong Buy, 27.27% Buy, 54.55% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 18.18% Strong Buy, 27.27% Buy, 54.55% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 18.18% Strong Buy, 27.27% Buy, 54.55% Hold, 0% Sell, 0% Strong Sell.

What is LeMaitre Vascular’s EPS forecast?

LeMaitre Vascular's average annual EPS forecast for its fiscal year ending in December 2025 is $2.16, marking a 10.20% increase from the reported $1.96 in 2024. Estimates for the following years are $2.38 in 2026, and $2.6 in 2027.

What is LeMaitre Vascular’s revenue forecast?

LeMaitre Vascular's average annual revenue forecast for its fiscal year ending in December 2025 is $240.15M, reflecting a 9.23% increase from the reported $219.86M in 2024. The forecast for 2026 is $258.75M, and $284.96M for 2027.

What is LeMaitre Vascular’s net income forecast?

LeMaitre Vascular's net income forecast for the fiscal year ending in December 2025 stands at $49.79M, representing an 13.06% increase from the reported $44.04M in 2024. Projections indicate $56.17M in 2026, and $58.19M in 2027.